Key facts
- This page summarizes Leone D. Patterson's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Feb 2024, 19:29.
Leone D. Patterson - 23 Feb 2024 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)
- Reporting relationship
- Chief Fin. and Bus. Officer
- Issuer ticker
- TNYA
- Reported as of
- 23 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Feb 2024, 19:29:46 UTC
- Prior SEC filing
- 16 Feb 2024
- Next SEC filing
- 14 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Drimmer Rokovich, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Leone D. Patterson filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 27 Feb 2024.
Change
- Previous filing in this sequence was filed on 16 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TNYA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +35,000
- Change %
- +58%
- Price
- $0.000000
- Shares after
- 95,755
- Date
- 23 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNYA
transaction
Derivative
Stock Option (Right to buy)
Award
- Transaction value
- $0
- Shares
- +205,000
- Change %
- Price
- $0.000000
- Shares after
- 205,000
- Date
- 23 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 205,000
- Exercise price
- $5.22
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock.
Footnote F2
The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2024, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested.
Footnote F3
Includes 75,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Footnote F4
Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.